ROCHE HOLDING AG Zu einer Liste hinzufügen
|
Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
| 265.60 CHF | +0.99% |
|
-3.14% | +8.63% |
| 13.09. | FDA genehmigt Roches Behandlung von Multipler Sklerose mit Halozyme Delivery System | MT |
| 13.09. | Roche-Tochter erhält FDA-Zulassung für Multiple-Sklerose-Behandlung | DJ |
Hauptkonkurrenten
Zu einer Liste hinzufügen 0 ausgewählt | Umsatz ($) (Y-1) | Nettomarge (Y-1) | Umsatzrendite (Y-1) | ROE (Y-1) | ROA (Y-1) | Verschuldungsgrad (Verbindlichkeiten / EBITDA) (Y-1) | |
|---|---|---|---|---|---|---|---|
| 69.26 Mrd. | +19,58% | +32,77% | +45,73% | +16,71% | 0.85x | ||
| 34.12 Mrd. | +15,36% | +20,68% | +48,93% | +9,23% | 2.6x | ||
| 34.51 Mrd. | +36,03% | +44,16% | +88,07% | +30,12% | -0.03x | ||
| 85.16 Mrd. | +41,28% | +32,25% | +34,91% | +14,32% | 0.21x | ||
| 54.32 Mrd. | +8,95% | +45,64% | +143,18% | +14,46% | 1.82x | ||
| 60.12 Mrd. | +0,61% | +10,33% | +9,18% | +3,56% | 2.77x | ||
| 45.81 Mrd. | +13,01% | +31,73% | +29,77% | +11,48% | 1.66x | ||
| 45.44 Mrd. | +32,69% | +36,03% | +25,37% | +12,37% | 0.67x | ||
| 28.19 Mrd. | +23,83% | +47,53% | +202,85% | +12,37% | 3.07x | ||
| 58.5 Mrd. | +3,62% | +15,90% | +11,37% | +4,96% | 3.8x | ||
| 47.75 Mrd. | +12,54% | +29,42% | +13,65% | +4,27% | 0.55x | ||
| 27.12 Mrd. | +20,89% | +38,66% | +38,46% | +13,49% | 1.34x | ||
| 45.01 Mrd. | +17,83% | +37,30% | +51,57% | +8,36% | 1.55x | ||
| 39.86 Mrd. | +16,25% | +28,97% | +52,48% | +10,55% | 1.29x | ||
| 7.91 Mrd. | +29,29% | +39,52% | +21,30% | +23,34% | -1.57x | ||
| 11.41 Mrd. | +12,53% | +13,21% | +12,80% | +7,95% | -2.01x | ||
| 14.86 Mrd. | +9,28% | +22,55% | +6,37% | +3,05% | 3.01x | ||
| 30.36 Mrd. | +3,38% | +5,02% | +2,10% | +0,36% | 4.66x | ||
| 3.22 Mrd. | +18,85% | +21,52% | +10,99% | +9,99% | -3.66x | ||
| Durchschnitt | 39.1 Mrd. | +17.67% | +29.11% | +44.69% | +11.10% | 1.19x | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | 45.69 Mrd. | +20.31% | +30.89% | +56.68% | +13.43% | 1.42x |
- Börse
- Aktien
- 855167 Aktie
- Sektor Roche Holding AG
- Finanzielle Vergleiche
MarketScreener is also available in this country: United States.
Switch edition
Bei der aktuellen länderspezifischen Edition bleiben